In one paragraphArticle in International archives of otorhinolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Karina LezirovitzLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0000-0002-7495-9789 Danillo Alencar-CoutinhoLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0000-0002-1984-6044 Stella Diogo-CavassanaLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0000-0001-9251-6466 Rafaella Abreu-OberhuberLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0009-0004-8245-3907 Juliana Sampaio-SilvaLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0000-0001-9668-9479 Maria Eduarda Paramo-NetoLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0009-0007-1647-7646 Regina Célia Mingroni-NettoDepartment of Genetics and Evolutionary Biology, Centro de Pesquisa Sobre o Genoma Humano e Células-Tronco (CEGH-CEL), Instituto de Biociências, Universidade de São Paulo (IBUSP), São Paulo, SP, Brazil.ORCID 0000-0001-9233-5227 Carlos Kazuo TaguchiDepartment of Speech-Language Pathology, Universidade Federal de Sergipe, Aracaju, SE, Brazil.ORCID 0000-0003-2428-0134 Ronaldo Carvalho Santos-JuniorDepartment of Otolaryngology, Faculdade de Medicina da Universidade Federal de Sergipe, Aracaju, SE, Brazil.ORCID 0000-0001-9705-9452 Ana Carla BatissocoLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0000-0003-4935-7687 Jeanne OiticicaLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0000-0001-9150-3962 Ricardo Ferreira BentoLaboratory of Molecular, Cellular, and Translational Genetic Otolaryngology (LIM32), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.ORCID 0000-0003-3749-4684 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Introduction: Hearing loss is genetically diverse, as it is caused by alterations in many genes and diverse inheritance patterns. While most causative variants are found in coding regions, noncoding regulatory variants can alter gene expression and may not be detected by standard exome sequencing analysis. Objective: To identify the genetic cause of autosomal dominant postlingual hearing loss in a large Brazilian family with 39 affected individuals and to describe their clinical features. Methods: Comprehensive audiological and imaging evaluations were conducted. Whole-exome sequencing on four affected subjects, supplemented by structural-variant analysis, identified a candidate variant later confirmed by quantitative polymerase chain reaction (qPCR), PCR, and Sanger sequencing. Results: Audiological testing of 61 relatives identified 31 individuals with progressive sensorineural hearing loss or auditory neuropathy linked to autosomal dominant inheritance. Genetic analysis revealed a Conclusion: Identification of this regulatory structural variant supports the role of
Indexed as
auditory neuropathy spectrum disorder (ANSD)complete exome sequencingDIAPH3 genehearing lossinsertion-deletion mutationsensorineural
Identifiers
PMID42345014
PMCPMC13288208
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390